Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 1958 entries
View as:

A Long-Term, Open-Label, Study on Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01129674 Org: User:
Start: 06/30/10 End: 10/31/12 Due: 10/31/13

A Study of Selpercatinib (LY3527723) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05338515 Org: User:
Start: 02/12/19 End: 03/26/19 Due: 03/26/20

A Study of Prasugrel in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01648790 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06692348 Org: User:
Start: 12/13/24 End: 06/09/25 Due: 06/09/26

Clinical Trial of Teriparatide in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00191867 Org: User:
Start: 02/28/05 End: 03/31/06 Due: 03/31/07

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01632306 Org: User:
Start: 03/31/13 End: 06/30/15 Due: 06/30/16

A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05469126 Org: User:
Start: 08/01/22 End: 11/03/22 Due: 11/03/23

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06370728 Org: User:
Start: 05/06/24 End: 07/23/24 Due: 07/23/25

A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00666718 Org: User:
Start: 04/30/08 End: 02/28/10 Due: 02/28/11

A Study of LY3209590 in Participants With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04450407 Org: User:
Start: 07/06/20 End: 10/01/21 Due: 10/01/22

Long-Term, Open Label Atomoxetine Study

Phase: N/A Priority: Normal
NCT ID: NCT00190684 Org: User:
Start: 08/31/00 End: 10/31/09 Due: 10/31/10

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00191620 Org: User:
Start: 03/31/04 End: 05/31/06 Due: 05/31/07

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Phase: N/A Priority: Normal
NCT ID: NCT02041091 Org: User:
Start: 01/31/14 End: 11/30/15 Due: 11/30/16

A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03310411 Org: User:
Start: 10/17/17 End: 12/23/17 Due: 12/23/18

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Phase: N/A Priority: Normal
NCT ID: NCT05659537 Org: User:
Start: 12/29/22 End: 01/16/24 Due: 01/16/25

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00109096 Org: User:
Start: 06/30/05 End: 03/31/07 Due: 03/31/08

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01175811 Org: User:
Start: 02/28/11 End: 11/30/12 Due: 11/30/13

A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02111083 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02513550 Org: User:
Start: 08/31/15 End: 08/03/17 Due: 08/03/18

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT01687478 Org: User:
Start: 09/30/12 End: 11/30/15 Due: 11/30/16

International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02065765 Org: User:
Start: - End: - Due: -

A Safety Study of LY3493269 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04498390 Org: User:
Start: 09/03/20 End: 12/28/20 Due: 12/28/21

A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05123586 Org: User:
Start: 03/07/22 End: 12/29/23 Due: 12/29/24

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00699998 Org: User:
Start: 06/30/08 End: 04/30/12 Due: 04/30/13

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Phase: N/A Priority: Normal
NCT ID: NCT05592275 Org: User:
Start: 02/03/23 End: 01/22/25 Due: 01/22/26